Ozempic is approved for diabetes but is often prescribed off-label for weight loss
A systematic review published in eClinicalMedicine analyzed 18 randomized controlled trials involving 3,771 participants and found that discontinuing GLP-1 receptor agonists resulted in an average weight regain of 5.63 kg, along with an HbA1c increase of 0.25%
As a result, individuals often experience a youthful glow and improved skin texture
Q: What should I do to prepare for the July 1 launch
Hug G, McGraw CA, Bates SR, et al
The EMA, which is similar to the FDA, reviewed non-clinical studies, clinical trials, post-marketing surveillance, and the medical literature regarding NAOIN and semaglutide drugs, like Ozempic